Sphinx Trading’s Trillium Therapeutics Inc. TRIL Stock Holding History

Sphinx Trading’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,000	Closed	-$176K	–	176
2021 Q3	$176K	Buy	+10,000	New	+$117K	0.18%	66

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Sphinx Trading's TRIL Position: Q4 2021 in Review

Sphinx Trading sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 10,000 shares — an estimated $176K sold.

Sphinx Trading first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $176K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Sphinx Trading reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Sphinx Trading sold 10,000 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $176K.
Sphinx Trading first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Sphinx Trading's Trillium Therapeutics Inc. position peaked at $176K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Sphinx Trading's 13F filing for Q4 2021, filed 31 Jan 2022.